Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
26.68
+0.34 (1.29%)
At close: Jun 26, 2026, 4:00 PM EDT
26.75
+0.07 (0.26%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.35 billion as of June 26, 2026. Its market cap has increased by 132.08% in one year.
Market Cap
2.35B
Enterprise Value
1.71B
1-Year Change
132.08%
Ranking
Category
Stock Price
$26.68
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.35B, an increase of 276.39%. That is a compound annual growth rate of 48.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.35B | -18.10% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vericel | 2.26B |
| Aurinia Pharmaceuticals | 2.22B |
| Kodiak Sciences | 2.22B |
| SELLAS Life Sciences Group | 2.22B |
| Ocular Therapeutix | 2.21B |
| Agios Pharmaceuticals | 2.19B |
| AbCellera Biologics | 2.17B |
| Nektar Therapeutics | 2.11B |